CIH exacerbates AD by activating microglia to trigger neuroinflammation, inducing astrocytic proliferation, promoting pathological tau protein accumulation, impairing synaptic plasticity, and influencing AD‐related gene expression [14, 20, 39, 51, 63]. This evidence concerns the gene MAPT and Alzheimer disease.